| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |